AMERIPRISE FINANCIAL INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$2,860,000
+508.5%
42,003
+209.8%
0.00%
Q1 2022$470,000
-54.7%
13,559
-61.7%
0.00%
Q4 2021$1,037,000
+97.1%
35,405
+135.6%
0.00%
Q2 2021$526,000
-60.2%
15,028
-53.6%
0.00%
Q1 2021$1,322,000
-12.3%
32,410
-6.9%
0.00%
-100.0%
Q4 2020$1,507,000
+12.2%
34,809
+42.8%
0.00%0.0%
Q3 2020$1,343,000
-67.0%
24,368
-62.2%
0.00%
-50.0%
Q2 2020$4,071,000
+225.9%
64,483
+164.0%
0.00%
+100.0%
Q1 2020$1,249,000
-48.4%
24,425
-19.9%
0.00%0.0%
Q4 2019$2,422,000
+116.8%
30,477
+32.4%
0.00%0.0%
Q3 2019$1,117,000
+3.1%
23,021
+11.9%
0.00%
Q2 2019$1,083,000
-1.1%
20,581
-0.6%
0.00%
-100.0%
Q1 2019$1,095,000
+133.0%
20,700
+80.2%
0.00%
Q4 2018$470,000
-78.9%
11,486
-76.7%
0.00%
-100.0%
Q2 2018$2,228,000
-38.5%
49,303
-34.3%
0.00%
-50.0%
Q1 2018$3,622,000
+192.1%
75,002
+138.1%
0.00%
+100.0%
Q4 2017$1,240,000
-2.8%
31,499
-23.4%
0.00%0.0%
Q3 2017$1,276,000
+14.5%
41,126
+1.0%
0.00%0.0%
Q2 2017$1,114,000
-26.2%
40,724
-0.6%
0.00%0.0%
Q1 2017$1,510,00040,9720.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Grace Capital 177,414$14,103,00011.50%
Fernwood Investment Management, LLC 258,012$20,509,0009.81%
Perceptive Advisors 5,865,726$466,266,0009.26%
ArchPoint Investors 186,756$14,845,0004.54%
STANSBERRY ASSET MANAGEMENT, LLC 115,638$9,192,0003.74%
Camber Capital Management LP 730,000$58,028,0002.95%
Profit Investment Management, LLC 46,873$3,726,0002.50%
Casdin Capital, LLC 300,000$23,847,0002.19%
SECTORAL ASSET MANAGEMENT INC 174,594$13,878,0002.07%
Corriente Advisors, LLC 40,000$3,180,0001.71%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders